Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01495130 · ClinicalTrials.gov registry record · NA

Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery

A NA study of Prostate Cancer, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT01495130: Completed NA study of Prostate Cancer, sponsored by University of Southern California.

NCT01495130 is a NA study of Prostate Cancer that has completed, run by University of Southern California. The registered enrollment target is 11 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01495130, a NA study of Prostate Cancer, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies mechanically-manipulated ultrasound in finding tumors during robotic-assisted surgery in patients with prostate cancer. Diagnostic procedures, such as ultrasound, may help find prostate cancer and find out how far the disease has spread during surgery

Conditions Studied

Interventions

  • PROCEDURE ultrasound imaging
  • PROCEDURE robot-assisted laparoscopic surgery

Study Locations (1)

California

  • USC/Norris Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2011-10
Est. Completion 2012-12
Phase NA
University of Southern California

617 total trials

What the finished NCT01495130 record still lists

NCT01495130 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which ultrasound imaging is the first listed.

NCT01495130 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01495130 about?

NCT01495130 is a clinical study titled "Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery". This pilot clinical trial studies mechanically-manipulated ultrasound in finding tumors during robotic-assisted surgery in patients with prostate cancer. Diagnostic procedures, such as ultrasound, may help find prostate cancer and find out how far the disease has spread during surgery

What is the current status of trial NCT01495130?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2011-10. Estimated completion is 2012-12.

What conditions does trial NCT01495130 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01495130?

The interventions under investigation include: ultrasound imaging (PROCEDURE), robot-assisted laparoscopic surgery (PROCEDURE).

Who is sponsoring clinical trial NCT01495130?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01495130 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01495130's enrollment target sits among peer trials

11 714th of 735 higher than 19 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01495130, the US trial registry maintained by the National Library of Medicine. NCT01495130 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.